Literature DB >> 16042070

Synthesis and anti-inflammatory testing of some new compounds incorporating 5-aminosalicylic acid (5-ASA) as potential prodrugs.

Abdel-Alim Mohamed Abdel-Alim1, Abdel-Nasser Ahmed El-Shorbagi, Samia Galal Abdel-Moty, Hajjaj Hassan Mohamed Abdel-Allah.   

Abstract

This work includes the synthesis of 15 final compounds (6a-h and 7b-h) as prodrugs of 5-ASA in the form of the acid itself, esters and amides linked by an amide linkage through a spacer to the endocyclic ring N of nicotinamide. Also, 15 new intermediate compounds were prepared. The target compounds (6b, 6f, 7b, and 7e-h) revealed potent analgesic and anti-inflammatory activities in comparison to sulfasalazine and 5-ASA. In addition, ulcerogenicity, LD50, in vivo and in vitro metabolism of compound 7f were determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042070     DOI: 10.1007/bf02969351

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug.

Authors:  Fatemeh Sadeghi; Atie Eidizade; Farinaz Saremnejad; Farzin Hadizadeh; Elham Khodaverdi; Abbas Akhgari
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

2.  N-[2-(4-Bromo-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide.

Authors:  Mehmet Akkurt; Ismail Celik; Hale Demir; Sumru Ozkırımlı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-19

3.  3-Ethyl-5-(4-meth-oxy-phen-oxy)-2-(pyridin-4-yl)-3H-imidazo[4,5-b]pyridine.

Authors:  S Ranjith; A Subbiahpandi; A D Suresh; K Pitchumani
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-22

4.  Crystal structure of methyl 2-hy-droxy-5-[(4-oxo-4,5-di-hydro-1,3-thia-zol-2-yl)amino]benzoate.

Authors:  Shaaban K Mohamed; Joel T Mague; Mehmet Akkurt; Hajjaj H M Abdu-Allah; Mustafa R Albayati
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.